Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression

Original Article

A. Reif, I. Bitter, J. Buyze, K. Cebulla, R. Frey, D.-J. Fu, T. Ito, Y. Kambarov, P.-M. Llorca, A.J. Oliveira-Maia, T. Messer, S. Mulhern-Haughey, B. Rive, C.v. Holt, A.H. Young, and Y. Godinov

N Engl J Med 2023;389:1298-1309

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
10/04/2023
Course expires: 
10/05/2025
Take course

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Take course